Join Now

Author Archives: Natalie Themm

IONIQ is “Clinical Diagnostics Solution of the Year 2022”

By Natalie Themm | Published December 21, 2022

IONIQ is “Clinical Diagnostics Solution of the Year 2022”

Posted in BioUtah News | Tagged | Leave a comment

IONIQ Science 2022 year-end update

By Natalie Themm | Published December 20, 2022

For IONIQ Sciences, 2022 was another big year. As we respond to the FDA’s substantive review of our De Novo application for the ‘breakthrough‘ IONIQ ProLung Test, powerful macroeconomic factors are highlighting the importance of early cancer detection. Despite uncertain conditions in the financial market, we have a compelling message for potential institutional and strategic investors at […]

Posted in BioUtah News | Tagged | Leave a comment

Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654 at the 64th ASH Annual Meeting & Exposition

By Natalie Themm | Published November 30, 2022

Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654

Posted in BioUtah News | Tagged | Leave a comment

NEW DIGITAL HEALTH INITIATIVE TO CREATE NEXT GENERATION OF MEDICAL APPS, GAMES, AND TECHNOLOGIES

By Natalie Themm | Published November 22, 2022

The University of Utah Health has launched NEW DIGITAL HEALTH INITIATIVE

Posted in BioUtah News | Tagged | Leave a comment

Teva Announces Appointment of Richard Francis as President and CEO

By Natalie Themm | Published November 21, 2022

Kåre Schultz to Retire After a Transformative Five-Year Tenure Setting the Stage for an Exciting Future

Posted in BioUtah News | Tagged | Leave a comment

CenExel Creates Clinical Sciences Business Unit

By Natalie Themm | Published November 15, 2022

CenExel announces a new Clinical Sciencesbusiness unit and more.

Posted in BioUtah News | Tagged | Leave a comment

Betty Iverson Retirement

By Natalie Themm | Published November 11, 2022

Betty Iverson Retirement Announced

Posted in BioUtah News | Tagged | Leave a comment

PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update

By Natalie Themm | Published November 11, 2022

PolarityTE provided a business update and reported financial results for the quarterly period ended September 30, 2022.

Posted in BioUtah News | Tagged | Leave a comment

PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company

By Natalie Themm | Published November 9, 2022

PolarityTE confirmed that on November 1, 2022, it received an unsolicited, non-binding offer (followed by an amended offer on November 8, 2022) from Michael Brauser to acquire all of the outstanding common stock of the Company not owned by him for $1.25 per share in cash.

Posted in BioUtah News | Tagged | Leave a comment

Clene Announces $10.8 Million Registered Direct Offering and $5 Million Debt Facility from the State of Maryland

By Natalie Themm | Published November 2, 2022

Clene announced that it has entered into a securities purchase agreement with certain existing stockholders.

Posted in BioUtah News | Tagged | Leave a comment

Clene Reports Topline Results Demonstrating Survival Signal for CNM-Au8® in Healey ALS Platform Trial

By Natalie Themm | Published November 2, 2022

The primary endpoint of adjusted ALSFRS-R and secondary endpoints of CAFS and SVC were not met at 24 weeks Prespecified exploratory analyses of the secondary survival endpoint for the 30 mg dose demonstrated a >90% reduction in risk of death or risk of death/permanently assisted ventilation at 24 weeks Survival signal consistent with prior results […]

Posted in BioUtah News | Tagged | Leave a comment

Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition of Gateway Genomics and Its Market-Leading SneakPeek® Early Gender DNA Test

By Natalie Themm | Published November 2, 2022

$67.5 million tuck-in acquisition strengthens Myriad’s Women’s Health portfolio of prenatal products.

Posted in BioUtah News | Tagged | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members